KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Amortization - Intangibles: 2016-2024

Historic Amortization - Intangibles for Emergent BioSolutions (EBS) over the last 9 years, with Dec 2024 value amounting to $65.1 million.

  • Emergent BioSolutions' Amortization - Intangibles changed negligibly% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 0.15%. This contributed to the annual value of $65.1 million for FY2024, which is 0.76% down from last year.
  • Emergent BioSolutions' Amortization - Intangibles amounted to $65.1 million in FY2024, which was down 0.76% from $65.6 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Amortization - Intangibles registered a high of $65.6 million during FY2023, and its lowest value of $58.5 million during FY2021.
  • For the 3-year period, Emergent BioSolutions' Amortization - Intangibles averaged around $63.5 million, with its median value being $65.1 million (2024).
  • Per our database at Business Quant, Emergent BioSolutions' Amortization - Intangibles declined by 2.17% in 2021 and then grew by 9.52% in 2023.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Amortization - Intangibles stood at $59.8 million in 2020, then decreased by 2.17% to $58.5 million in 2021, then rose by 2.39% to $59.9 million in 2022, then climbed by 9.52% to $65.6 million in 2023, then dropped by 0.76% to $65.1 million in 2024.